Please activate JavaScript!
Please install Adobe Flash Player, click here for download

SAfW Wundkompendium

Wund Management Sonderheft 3/2012 · 67 Wundinfektionen 79. Sopata M, Ciupinska M, Glowacka A: Effect of octenisept antiseptic on bioburden of neoplastic ulcers in patients with advan- ced cancer. J Wound Care 2008; 17: 24-27. 80. Spann C T, Tutrone W D, Weinberg J M, Scheinfeld N, Ross B: Topical antibacteri- al agents for wound care: a primer. Derma- tol Surg 2003; 29: 620–626. 81. Subrahmanyam M: Honey-impregnated gauze versus amniotic membrane in the tre- atment of burns. Burns 1994; 20: 331–333. 82. Subrahmanyam M: Honey dressing ver- sus boiled potato peel in the treatment of burns: a prospective randomized study. Burns 1996; 22: 491–493. 83. Subrahmanyam M: Honey impregnated gauze versus polyurethane film (OpSite) in the treatment of burns-a prospective randomised study. Br J Plast Surg 1993; 46: 322–323. 84. Subrahmanyam M: A prospective ran- domised clinical and histological study of superficial burn wund healing with honey and silver sulfadiazine. Burns 1998; 24: 157–161. 85. Sundberg J, Meller R: A retrospective review of the use of cadexomer iodine in the treatment or chronic wounds. Wounds 1997; 9: 68–86. 86. Tammelin A, Lindholm C, Hambraeus A: Chronic ulcers and antibiotic treatment. J Wound Care 1998; 7: 435–437. 87. The International Working Group on the Diabetic Foot: The International Con- sensus on the Diabetic Foot. 1999. 88. Trengove N J, Stacey M C, McGechie D F, Mata S: Qualitatitive bacteriology and leg ulcer healing. J Wound Care 1996; 5: 6. 89. Valencia I, Kirsner R, Kerdel F: Micro- biologic evaluation of skin wounds: alar- ming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period. J Am Acad Dermatol 2004; 50: 845–849. 90. Valtonen V, Karppinen L, Kariniemi A L: A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. Scand J Infect Dis Suppl 1989; 60: 79–83. 91. Vanscheidt W, Harding K, Téot L, Sieb- ert J: Effectiveness and tissue compatibili- ty of a 12-week treatment of chronic venous leg ulcers with an octenidine based anti- septic - a randomized, double-blind control- led study. Int Wound J 2012; 9: 316–323. 92. Vermeulen H, van Hattem J M, Storm- Versloot M N, Ubbink D T: Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007; Jan 24. 93. Vriens M, Blok H, Fluit A, Troelstra A, Van Der Werken C, Verhoef J: Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21: 782–786. 94. Yamasaki O, Kaneko J, Morizane S, Akiyama H, Arata J, Narita S, Chiba J, Kamio Y, Iwatsuki K: The association bet- ween Staphylococcus aureus strains carry- ing panton-valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005; 40: 381–385. Wirksamkeit und in-vitro-Zytotoxizität von Lavasept und Prontosan. GMS Kranken- haushy Interdiszip 2007; 2: Doc42. 63. Münter K C, Beele H, Russell L, Crespi A, Gröchenig E, Basse P, Alikadic N, Fraulin F, Dahl C, Jemma A P: Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J Wound Care 2006; 15: 199–206. 64. Niedner R: Experimentelle Beeinflussung der Wundheilung durch lokale antimikro- bielle Substanzen. Zbl Haut Geschlechtskr 1993; 162: 647–657. 65. O‘ Meara S, Al-Kurdi D, Ovington L: Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008; Jan 23. 66. Olivieri J, Eigenmann P A, Hauser C: Severe anaphylaxis to a new disinfectant: polyhexanide, a chlorhexidine polymer. Schweiz Med Wochenschr 1998; 128: 1508–1511. 67. Percival S L, Bowler P G, Russell D: Bacterial resistance to silver in wound care. J Hosp Infect 2005; 60: 1–7. 68. Phillips D, Pearson R L, Miller G A: Wound cleansing versus wound disinfec- tion: a challenging dilemma. Perspectives 1991; 21: 15–16. 69. RKI-Ratgeber Infektionskrankheiten: Staphylokokken-Erkrankungen, insbeson- dere Infektionen durch MRSA. 2007. 70. Robson M, Mannari R, Smith P, Payne W: Maintainance of wound bacterial balan- ce. Am J Surg 1999; 178: 399–402. 71. Robson M C: Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997; 77: 637–650. 72. Saap L, Fahim S, Arsenault E, Pratt M, Pierscianowski T, Falanga V, Pedvis- Leftick A: Contact sensitivity in patients with leg ulcerations: a North American study. Arch Dermatol 2004; 140: 1241–1246. 73. Sapico F, Ginunas V J, Thornhill-Joy- nes M, Canawati H N, Capen D A, Klein N E, Khawam S, Montgomerie J Z: Quan- titative microbioloby of pressure sores in different stages of healing. Infect Dis 1986; 5: 31–38. 74. Sato T, Miyata G: The nutraceutical benefit, part III:honey. Nutrition 2000; 16: 468–469. 75. Schultz G S, Sibbald R G, Falanga V, Ayello E A, Dowsett C, Harding K G, Romanelli M, Stacey M C, Téot L, Vanscheidt W: Wound bed prepara- tion: a systematic approach to wound management. Wound Repair Regen 2003; 11: S1–S28. 76. Scottish Intercollegiate Guidelines Network SIGN: The care of patients with chronic leg ulcer. A national clinical guideli- ne. SIGN Publication, Edinburgh, UK 1998; No. 26. 77. Sibbald R G, Williamson D, Orsted H L, Campbell K, Keast D, Krasner D, Sib- bald D: Preparing the wound bed - Debri- dement, bacterial balance and mosiure balance. Ostomy Wound Manage 1999; 46: 14–35. 78. Siegel J, Rhinehart E, Jackson M, Chiarello L: Management of multidrug- resistant organisms in healthcare settings. Healthcare Infection Control Practices Advi- sory Committee. 2006; ne, octenidine dihydrochloride, polyhexani- de and chlorhexidine digluconate. J Antimi- crob Chemother 2010; 65: 1712–1719. 48. König S: Wirksamkeit und Verträglichkeit von liposomalem PVP-Iod-Hydrogel bei der Behandlung des Ulcus cruris. Inaugural Dissertation Albert-Ludwig-Universität Frei- burg 2005. 49. Kramer A, Daeschlein G, Kammer- lander G, Andriessen A, Aspöck C, Bergemann R, Eberlein T, Gerngross H, Görtz G, Heeg P, Jünger M, Koch S, König B, Laun R, Peter R U, Roth B, Ruef C, Sellmer W, Wewalka G, Eisenbeiß W: Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundanti- septik. ZfW 2004; 9: 110–120. 50. Kramer A, Roth B, Müller G, Rudolph P, Klöcker N: Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental super- ficial aseptic wounds in piglets. A double- blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physi- ol 2004; 17: 141–146. 51. Kramer S A: Effect of povidone-iodine on wound healing: a review. J Vasc Nurs 1999; 17: 17–23. 52. Lazzarini L, Conti E, Tositti G, de Lalla F: Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 2005; 51: 383–389. 53. Levine N, Lindberg R, Mason A J, Pruitt B J: The quantitative swab culture and sme- ars: a quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma 1976; 16: 89–94. 54. Linde H, Lehn N: Methicillin-resistant Staphylococcus aureus (MRSA) - diagno- sis. Dtsch Med Wochenschr 2005; 130: 582–585. 55. Linde H, Lehn N: Methicillin-resistant Sta- phylococcus aureus (MRSA) - therapy and hygienic measures. Dtsch Med Wochenschr 2005 130: 586–588. 56. Lipsky B A: Evidence-based antibiotic the- rapy of diabetic foot infections FEMS Immu- nol Med Microbiol 1999; 26: 267–276. 57. Mancuso G, Staffa M, Errani A: Acetic acid in the treatment of superinfected leg ulcers. Chronica Dermatologica 1994; 4: 473–478. 58. Meaume S, Vallet D, Morere M N, Téot L: Evaluation of a silver-releasing hydroalgi- nate dressing in chronic wounds with signs of local infection. J Wound Care 2005; 14: 411–419. 59. Mehtar S, Fox D: A double-blind compa- rative study with mupirocin vs placebo base in the treatment of chronic leg ulcers. Br J Clin Pract 1988; 42: 324–328. 60. Moore O A, Smith L A, Campbell F, Seers K, McQuay H J, Moore R A: Sys- tematic review of the use of honey as a wound dressing. BMC Complement Altern Med. 2001; Epub 2001 Jun 2004. 61. Moran G, Krishnadasan A, Gorwitz R, Fosheim G, McDougal L, Carey R, Talan D: Methicillin-resistant S. aureus infections among patients in the emergency depart- ment. N Engl J Med 2006; 355: 666–674. 62. Müller G, Koburger T, Jethon F U W, Kramer A: Comparison of the bactericidal efficacy and in vitro cytotoxicity of Lavasept and Prontosan. Vergleich der bakterioziden

Seitenübersicht